My research direction during my graduate school is closely related to biological research, and the outbreak of the epidemic has made people pay more attention to the importance of biopharmaceutical technology, and the efficacy of drugs is closely related to the onset time.
In terms of specialized courses, liberal arts students are not recommended to choose. Because there is no foundation of physics or chemistry in high school, it will be quite difficult to study biology/pharmacy courses. Basic chemistry courses include biology, analytical chemistry, organic chemistry, inorganic chemistry, biochemistry and so on. Then. In the third year or so, I will take some professional courses, and then I will divide the pharmacy major into pharmaceutical analysis, medicinal chemistry, pharmaceutical preparations, pharmacology and other majors, which is also the direction of postgraduate entrance examination.
In addition, I think biopharmaceutical study should go to a better school. Biology/pharmacy, a first-level discipline, is a two-level discipline. Whether you take the public examination or enter the enterprise or the hospital, it is very popular for future employment. However, if it is a relatively ordinary school, it is suggested that the academic qualifications can be improved a little.
Social recognition: in some fast-developing first-and second-tier cities, the salary of pharmacy can be really high, but in some backward places, students can't find good jobs. If you want to go home after graduation, you can only take the public exam, and then there will be fewer corresponding majors. Therefore, it is suggested that we must develop in a better city first. At present, biopharmaceuticals are superior to the development of Chinese and western medicines, which has a bright future.
On the whole, pharmaceutical biotechnology will be a key industry for a long time at present and in the future. If you are interested in pharmacy, you can consider it more.
Under the background of epidemic situation, medical biotechnology has great employment prospects on the one hand, and is also making contributions to the progress of life science on the other. The main reason is that the epidemic situation develops and mutates too fast, and there is a shortage of research and development talents for vaccines and antibodies. Moreover, there is no specific medicine for COVID-19, and this research will definitely have a lot of investment. So the research and development of biotechnology is very promising.